Incidence of cancer among commercial airline pilots

Occupational and Environmental Medicine

Volumn 57, Issue 3, 2000, Pages 175-179

  Rafnsson, Vilhjálmur ^a   Hrafnkelsson, Jón ^b   Tulinius, Hrafn ^a,c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Department of Oncology ^*  (Iceland)

^c ICELANDIC CANCER REGISTRY   (Iceland)

Author keywords

Block hours; Cancer registry; Cosmic radiation; Malignant melanoma of the skin; Time zones

Indexed keywords

AIRPLANE PILOT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CIRCADIAN RHYTHM; COHORT ANALYSIS; CONTROLLED STUDY; COSMIC RADIATION; ENVIRONMENTAL EXPOSURE; HUMAN; ICELAND; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MELANOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SUNBURN;

AEROSPACE MEDICINE; COHORT STUDIES; COSMIC RADIATION; HUMANS; ICELAND; INCIDENCE; MALE; MELANOMA; NEOPLASMS; OCCUPATIONAL DISEASES; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0034063625     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.57.3.175     Document Type: Article

References (38)

1. 1 Band PR, Spinelli JJ, Ng VTY, et al. Mortality and cancer incidence in a cohort of commercial airline pilots. Aviat Space Environ Med 1990;61:299-302.
2. 2 Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: mortality, cancer incidence and leukemia risk. Am J Epidemiol 1996;143:137-43.
3. 3 Kaji M, Tango T, Asukata I, et al. Mortality experience of cockpit crewmembers from Japan Airlines. Aviat Space Environ Med 1993;64:748-50.
4. 4 Irvine D, Davies DM. British Airways flightdeck mortality study, 1950-92. Aviat Space Environ Med 1999;70:548-55.
5. 5 Salisbury DA, Band PR, Threfall WJ, et al. Mortality among British Columbia pilots. Aviat Space Environ Med 1991;62: 351-2.
6. 6 Irvine D, Davies DM. The mortality of British Airways pilots 1966-89: a proportional mortality study. Aviat Space Environ Med 1992;63:276-9.
7. 7 Vågerö D, Swerdlow AJ, Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990;47: 317-24.
8. 8 Grayson JK, Lyons TJ. Cancer incidence in United States air force aircrew, 1975-89. Aviat Space Environ Med 1996; 67:101-4.
9. 9 Hoiberg A, Blood C. Age-specific morbidity among navy pilots. Aviat Space Environ Med 1983;54:912-18.
10. 10 Grayson JK. Radiation exposure, socioeconomic status, and brain tumor risk in the US air force: a nested case-control study. Am J Epidemiol 1996;143:480-6.
11. 11 Grayson JK, Lyons TJ. Brain cancer, flying, and socioeconomic status: a nested case-control study of USAF aircrew. Aviat Space Environ Med 1996;67:1152-4.
12. 12 Blettner M, Grosche B, Zeeb H. Occupational cancer risk in pilots and flight attendants: current epidemiological knowledge. Radiat Environ Biophys 1998;37:75-80.
13. 13 Friedberg W, Faulkner DN, Snyder L, et al. Galactic cosmic radiation exposure and associated health risk for air carrier crewmembers. Aviat Space Environ Med 1989;60:1104-8.
14. 14 Bagshaw M, Irvine D, Davies DM. Exposure to cosmic radiation of British Airways flying crew on ultralonghaul routes. Occup Environ Med 1996;53:495-8.
15. 15 Tveten U. Cosmic radiation and airline pilots. Exposure pattern of Norwegian SAS-pilots 1960-94. Kjeller: Instute for Energy Technology, 1997.
16. 16 Nicholas JS, Lackland DT, Butler GC, et al. Cosmic radiation and magnetic field exposure to airline flight crews. Am J Ind Med 1998;34:547-80.
17. 17 Potter JD, Slatter ML, Gastrup SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545.
18. 18 Steinthórsson SB, Axelsson AG, Snorrason S. Flugmannatal. (Register of Pilots). Reykjavik: Félag islenskra atvinnuflugmanna, 1988.
19. 19 Tulinius H, Ragnarsson J. Cancer incidence in Iceland 1955-84. Reykjavik, Cancer Society and Director General of Health, 1987.
20. 20 Breslow NE, Day NE. Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987.
21. 21 McDonald JC, Liddel FDK, Gibbs GW, et al. Dust exposure and mortality in chrysotile mining, 1910-75. Br J Ind Med 1980;37:11-24.
22. 22 Gallagher RP, Elwood JM, Threlfall WJ, et al. Occupation and risk of cutaneous melanoma. Am J Ind Med 1986;9:289-94.
23. 23 Goodman KJ, Bible ML, London S, et al. Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control 1995;6:451-9.
24. 24 Fritschi L, Siemiatycki J. Melanoma and occupation: results of a case-control study. Occup Environ Med 1996;53:168-73.
25. 25 Armstrong BK, English DR. Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996.
26. 26 Holman CDJ, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Linos melanoma research project. Recent Results Cancer Res 1986;102:18-37.
27. 27 Austin DF, Reynolds P. Occupation and malignant melanoma of the skin. Recent Results Cancer Res 1986;102: 98-107.
28. 28 Schwartzbaum JA, Setzer RW, Kupper LL. Exposure to ionizing radiation and risk of cutaneous malignant melanoma. Search for error and bias. Ann Epidemiol 1994;4:487-96.
29. 29 Pion IA, Rigel DS, Garfinkel L, et al. Occupation and risk of malignant melanoma. Cancer 1995;15(suppl):637-44.
30. 30 Acquavella JF, Wilkinson GS, Tietjen GL. A melanoma case-control study at the Los Alamos National Laboratory. Health Phys 1983;45:587-92.
31. 31 Kendall GM, Muirhead CR, MacGibbon BH, et al. Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. BMJ 1992;304:220-5.
32. 32 Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-87. Radiat Res 1994;137:S17-67.
33. 33 Parkin DM, Muir CS, Whelan SL, et al. Cancer incidence in five continents. Vol VI. Lyon: International Agency for Research on Cancer, 1992.
34. 34 Hu DN, McCormick SA, Roberts JE. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. Melanoma Res 1998;8:205-10.
35. 35 Lissoni P, Brovio O, Brivio F, et al. Adjuvant therapy with pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. J Pineal Res 1996;21: 239-42.
36. 36 Jonsson JG, Magnusson B, Tulinius H, et al. Malignant melanoma in Iceland 1955-84. Læknabla∂i∂ 1985;71:274-81.
37. 37 Holly EA, Aston DA, Ahn DK, et al. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology 1996;7:55-61.
38. 38 Gallagher RP, Elwood JM, Rootman J, et al. Risk factors for ocular melanoma: west Canada melanoma study. J Natl Cancer Inst 1985;74:775-8.